River Global Investors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
River Global Investors's GILD Position: Q4 2024 in Review
River Global Investors reduced its Gilead Sciences (GILD) stake by 45% in Q4 2024, selling an estimated $711K and leaving 9,535 shares worth $881K. The position accounts for 0.17% of the portfolio, ranked #110.
River Global Investors first reported a position in GILD in Q3 2016 and has held it in 22 quarters since. The position peaked at $5M in Q2 2020. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.
- River Global Investors held 9,535 shares of Gilead Sciences worth $881K as of Q4 2024.
- River Global Investors sold 7,892 Gilead Sciences shares in Q4 2024, an estimated $711K.
- Gilead Sciences made up 0.17% of River Global Investors's portfolio in Q4 2024, its #110 holding.
- River Global Investors first reported a position in Gilead Sciences in Q3 2016 and has held it in 22 quarters since.
- River Global Investors's Gilead Sciences position peaked at $5M in Q2 2020.
- 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.
Based on River Global Investors's 13F filing for Q4 2024, filed 7 Feb 2025.